| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/01/2006 | CN1239495C Fungicides for control of take-all disease of plants |
| 02/01/2006 | CN1239472C HIV integrase inhibitors |
| 01/31/2006 | US6992220 useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C. |
| 01/31/2006 | US6992081 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/31/2006 | US6992076 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
| 01/26/2006 | US20060020146 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 01/26/2006 | US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
| 01/26/2006 | US20060018846 Animo substituted hydroxyphenyl benzophenone derivatives |
| 01/26/2006 | CA2574625A1 Process for the preparation of (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester |
| 01/25/2006 | EP1617803A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 01/25/2006 | CN1726303A Atomic layer deposition using metal amidinates |
| 01/25/2006 | CN1726184A Animo substituted hydroxyphenyl benzophenone derivatives |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | CA2350881C Wet adhesion monomer and derived copolymers for latex paints |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | CA2573378A1 Amide derivatives as inhibitors of histone deacetylase |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723194A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1723192A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 01/18/2006 | CN1721409A Dibenzo(b,f)azepine derivatives |
| 01/18/2006 | CN1721407A New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 01/18/2006 | CN1721393A Process for preparing 5-acetamino-N,N'-bis (2,3-dihydroxypropyl)-2,4,6-tri-iodo isophthalamide |
| 01/12/2006 | WO2006003923A1 Substituted benzene compound |
| 01/12/2006 | US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/10/2006 | US6984642 for treating cardiovascular disorders, for example for the acute and chronic treatment of ischaemic disorders |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/05/2006 | WO2006000288A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 01/05/2006 | WO2005035553A3 Conjugation of peptides |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060003971 such as A-ring aromatized Minocycline, having antibacterial activity; antibiotics |
| 01/05/2006 | CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | CN1234681C Amino acid derivatives and their use as pesticides |
| 01/03/2006 | US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents |
| 01/03/2006 | US6982092 Method of complexing a nucleic acid with a lipid-conjugated polyamide |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 12/29/2005 | WO2005123700A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/29/2005 | WO2005123660A2 Polycationic compounds and uses thereof |
| 12/29/2005 | WO2005077122A3 Compounds and compositions as lxr modulators |
| 12/29/2005 | US20050288486 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288262 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression |
| 12/29/2005 | US20050288228 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 12/29/2005 | US20050287114 Water-soluble polymeric bone-targeting drug delivery system |
| 12/29/2005 | DE19748040B4 Carbonsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten Carboxylic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds |
| 12/29/2005 | CA2570248A1 Polycationic compounds and uses thereof |
| 12/29/2005 | CA2568539A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/28/2005 | EP1608688A2 Branched water-soluble polymers and their conjugates |
| 12/28/2005 | EP1608674A1 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants |
| 12/28/2005 | EP1608616A1 Biphenyl carboxylic amide p38 kinase inhibitors |
| 12/28/2005 | EP1414438B1 Antineoplastic combinations |
| 12/28/2005 | EP1002790B1 Sphingosine analogues |
| 12/27/2005 | US6979749 from non-carcinogenic raw materials, employing Suzuki type biaryl coupling as key step; use of palladacycle as catalyst with turnover number in the range of 6 to 10. |
| 12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
| 12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
| 12/22/2005 | WO2005121291A1 Surfactant composition method for production thereof and cosmetic comprising said composition |
| 12/22/2005 | WO2005121082A1 Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation |
| 12/22/2005 | WO2005121073A1 Inhibitors of histone deacetylase |
| 12/22/2005 | WO2005120148A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 12/22/2005 | WO2005061443A3 Benzoyl-substituted phenylalanine amides |
| 12/22/2005 | WO2004098512A3 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 12/22/2005 | US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease |
| 12/22/2005 | US20050282882 Diamines as modulators of chemokine receptor activity |
| 12/22/2005 | US20050282787 Synthesis of tetracyclines and analogues thereof |
| 12/22/2005 | CA2568700A1 Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation |
| 12/21/2005 | EP1606244A2 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant |
| 12/21/2005 | EP1606243A1 Process for the preapaation of chiral beta amino acid derivatives by asymmetric hydrogenation |
| 12/21/2005 | CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 12/21/2005 | CN1711236A Nitroaniline-based alkylating agents and their use as prodrugs |
| 12/20/2005 | CA2171275C Stilbene derivatives and pharmaceutical compositions containing them |
| 12/15/2005 | WO2005075455A3 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 12/15/2005 | WO2005062874A3 Compounds and compositions for delivering active agents |
| 12/15/2005 | WO2004083258A3 Branched water-soluble polymers and their conjugates |
| 12/15/2005 | US20050277690 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/15/2005 | US20050277592 Beta-peptides |
| 12/15/2005 | DE19507294B4 Verfahren zur Herstellung und Reinigung iodierter Kontrastmittel A process for the preparation and purification of iodinated contrast agents |
| 12/15/2005 | DE102004022628A1 FRET-Bioassay FRET bioassay |
| 12/14/2005 | EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses |
| 12/14/2005 | EP1604975A1 Processes for production of (r)-3- 4-(trifluoromethyl)- phen ylamino pentanamide derivatives |
| 12/14/2005 | EP1604212A2 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders |
| 12/14/2005 | EP1603546A1 Glycinamide derivative for inhibiting hiv replication |
| 12/14/2005 | EP1263712B1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 12/14/2005 | CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 12/14/2005 | CN1706816A Theanine preparing process |
| 12/14/2005 | CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
| 12/13/2005 | US6974882 Preparation of iodixanol |
| 12/13/2005 | US6974836 Diamines as modulators of chemokine receptor activity |
| 12/08/2005 | WO2005115972A1 Therapeutic compounds |
| 12/08/2005 | WO2005082860A8 Tetracyclines and their use as calpain inhibitors |
| 12/08/2005 | US20050272815 Compounds and compositions for delivering active agents |
| 12/08/2005 | US20050272710 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
| 12/08/2005 | DE102004023632A1 Substituierte Cyclohexylcarbonsäure-Derivate Substituted cyclohexyl carboxylic acid derivatives |
| 12/08/2005 | DE102004023508A1 Säurederivate substituierter Cyclohexyl-1,4-diamine Acid derivatives substituted cyclohexyl-1,4-diamine |
| 12/08/2005 | CA2565066A1 Therapeutic compounds |
| 12/07/2005 | EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 12/07/2005 | EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |